Despite challenges like high treatment costs, the market is anticipated to expand further, fueled by increasing clinical evidence, new regulatory approvals for additional indications, and the development of more affordable alternatives
Practical Clinical Implications 7.1 Population-Specific Cardiorenal Efficacy Type 2 diabetes with established ASCVD or CKD
That longer titration is intentional
In 2024, the Centers for Disease Control and Prevention (CDC) released a report stating that 1 in 8 Americans had diabetes
For example, in a separate pooled analysis of 4 major clinical trials reporting cardiovascular events in patients with T2D and CKD, Kelly et al
Clinical significance of probiotics for children with idiopathic nephrotic syndrome